HEATHER MAGGIO: Open Payments
NPI 1922634757 · LATHAM, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,253 in 52 payments from 21 companies in 2025. Trend: 2023 $1,632 · 2024 $1,655 · 2025 $1,253
Food & beverage: $1,240Education: $13
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $249 |
| Janssen Biotech, Inc. | 8 | $175 |
| AstraZeneca Pharmaceuticals LP | 3 | $161 |
| Daiichi Sankyo Inc. | 9 | $135 |
| Novartis Pharmaceuticals Corporation | 3 | $74 |
| Astellas Pharma US Inc | 2 | $61 |
| Merck Sharp & Dohme LLC | 2 | $47 |
| EMD Serono, Inc. | 2 | $45 |
| Incyte Corporation | 2 | $41 |
| Genentech USA, Inc. | 2 | $41 |
Products named: SARCLISA, DATROWAY, Enhertu, RYBREVANT, ERLEADA, KEYTRUDA, TALVEY, JAKAFI.
Industry payments across NY — which companies pay providers there.
